Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
2020 Indiana Code Title 25. Professions and Occupations Article 26. Pharmacists, Pharmacies, Drug Stores Chapter 24. Central Repository for Controlled Substances Data 25-26-24-2.5. "Controlled Substance" H.E.A. 1182, P.L. 84 Effective: March 12, 2024 Makes amendments to the list of Schedule I, II, and IV controlled substances. Read the bill at: We would like to show you a description here but the site won’t allow us. Indiana’s drug laws are a critical area of focus due to their complexities and significant impact on individuals and communities. Understanding these laws is crucial as they dictate the classification of controlled substances and outline offenses related to possession and distribution. Classification of Controlled Substances Indiana’s classification of controlled substances is governed by 2024 Indiana Code Title 25. Professions and Occupations Article 26. Pharmacists, Pharmacies, Drug Stores Chapter 24. Central Repository for Controlled Substances Data 25-26-24-2.5. "Controlled Substance" Gabapentin closely resembles pregabalin, a schedule V drug under the Controlled Substances Act in its chemical structure and pharmacological activity. The chemical structure of gabapentin is derived from the addition of a lipophilic cyclohexyl group to the backbone of gamma-aminobutyric acid (GABA). Gabapentin is not classified as a controlled substance on the federal level. However, there are growing concerns about the potential risks. Here’s what to know. Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. In general, medications classified as Schedule V (Schedule 5) controlled substances are considered to have the lowest potential for abuse compared to other controlled schedules, but may still pose a risk of As of June 2024, gabapentin remains a non-controlled substance under the U.S. federal government. With mounting evidence of misuse and abuse of gabapentin use, certain states have implemented regulations or policies to limit or monitor the use of the drug, especially given its potential to enhance the effects of opioids. On a federal level, gabapentin is not a controlled substance. However, because of increasing numbers of prescriptions and reports of misuse and harm, gabapentin is a controlled substance in some US states, with certain other states requiring gabapentin prescriptions to be reported to state databases. Gabapentin can be dangerous when used in combination with other drugs, especially alcohol and The Legal Foundation: Indiana’s Controlled Substance Reporting Requirements The Indiana controlled substance reporting rules are rooted in Indiana Code 25-26-24 and enforced by the Indiana Board of Pharmacy, as detailed in 856 IAC 1 . The core mandate: all dispensations of Schedule II through V controlled substances, as well as certain other medications like gabapentin, must be reported to Controlled Substances July 1, 2016: Pursuant to Indiana Code 25-26-13-4, ephedrine and pseudoephedrine, when dispensed via prescription, are each considered a "controlled substance" for the purposes of the INSPECT program. All prescription dispensations of these drugs must be reported to INSPECT. H.E.A. 1056, P.L. 2-2025 Effective: July 1, 2025 Adds additional substances to the list of controlled substances. Read the bill at: To date, the following states have also taken steps to classify gabapentin as a controlled substance: Alabama Michigan North Dakota Utah Virginia Although gabapentin is not a controlled substance in the following states, there is stricter prescription monitoring for potential misuse. As of April 2025, these states include: Connecticut Indiana Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. The INSPECT program monitors all prescriptions for ephedrine, pseudoephedrine, and controlled substances. "Controlled Substance" has the meaning set forth in IC 35-48-1-9. The term includes gabapentin. Click here for a list of the drugs as described in the Federal Controlled Substances Act. Am I permitted to share INSPECT information? Important Notice regarding Changes to Indiana Law concerning the Prescribing and Dispensing of Opioids: ATTENTION - Effective July 1, 2017, pursuant to Senate Enrolled Act 226, new laws concerning the prescribing and dispensing of opioids will go into effect. Please be advised, these changes affect any practitioner who maintains an Indiana controlled substance registration and a federal Drug Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial The “drug of concern” classification in Indiana has specific legal implications for possession, distribution, and prescription practices. While not as restrictive as controlled substance regulations, it requires careful compliance to avoid legal consequences. Possession Possession of gabapentin in Indiana requires a valid prescription. Controlled Substances July 1, 2016: Pursuant to Indiana Code 25-26-13-4, ephedrine and pseudoephedrine, when dispensed via prescription, are each considered a "controlled substance" for the purposes of the INSPECT program. All prescription dispensations of these drugs must be reported to INSPECT.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |